MedPath

The effect of Panchnnimbadi Churna and an etiopathological study on urticaria (sheetpitta)

Phase 2
Not yet recruiting
Conditions
Allergic urticaria. Ayurveda Condition: SITAPITTAM,
Registration Number
CTRI/2025/04/085758
Lead Sponsor
Dr Sunil Kumar
Brief Summary

THIS STYDY IS SINGLE ARM TRIAL TO KNOW THE EFFECTNESS OF PANCHNIMBADI CHURN IN URTICARIA (SHEETPITTA) THAT WILL BE CONDUCTED IN GOVERMENT AYURVEDIC COLLEGE AND HOSPITAL PATNA , IN THE DEPARTMENT OF ROG NIDIAN EVAM VIKRITI VIGYAN IN THE GROUP 30 PATIENTS AFTER THE 15 DAYS INTERVENTIONS, FOLLOW UP IS DONE AT EVERY 15 DAYS FOR THE ENTIRE DURATION OF THE STUDY, i,e  60 DAYS.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

The sign and symptoms of Urticaria (Sheetpitta) based on both ayurvedic as well as modern view.

Exclusion Criteria
  • Patients below 12 years and above 60 years.
  • Immunocompromised patients example HIV.
  • Patients is unwillings.
  • Patients with complicated associated symptoms example severly ill liver cirrhosis adenocarcinoma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sign and symptoms will be assessed before and after treatment. i.e- Kandu, Mandalakar, Utsedna, Toda, Daha, Sotha etcTotal 30 Patients | Duration- 60 Days
Secondary Outcome Measures
NameTimeMethod
CBC & LFT test will be done in patients before & after treatmentTotal- 30 Patients

Trial Locations

Locations (1)

GOVERNMENT AYURVEDIC COLLEGE AND HOSPITAL PATNA

🇮🇳

Patna, BIHAR, India

GOVERNMENT AYURVEDIC COLLEGE AND HOSPITAL PATNA
🇮🇳Patna, BIHAR, India
DR SUNIL KUMAR
Principal investigator
7677667238
bamssunilkumar@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.